Search research articles
Contact Us
Filters
Showing results (191-200 of 206) with videos related to
Page
of 21
Sort By:
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2018
Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in <i>FLT3</i>-Mutant Acute Myeloid Leukemia
Xuejie Jiang, Po Yee Mak, Hong Mu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2024
Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung Cancer
Mitchell S von Itzstein, Timothy F Burns, Jonathan E Dowell, et al.
Leukemia
|
May 26, 2019
Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia
Takenobu Nii, Varun V Prabhu, Vivian Ruvolo, et al.
Journal for Immunotherapy of Cancer
|
October 28, 2025
Genetic haplotypes in <i>VWA8, OSBPL6,</i> and <i>ADAMTS9-AS2</i> are associated with immune-related adverse effects in ICI-treated patients with cancer
Prithvi Raj, Jialiang Liu, Chengsong Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2017
Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia
Lina Han, Jeffrey L Jorgensen, Chris Brooks, et al.
JTO Clinical and Research Reports
|
December 2, 2024
Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer
Mitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Differences in systemic immune parameters in individuals with lung cancer according to race
Mitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.
Oncotarget
|
March 1, 2018
Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in <i>CRLF2</i> rearranged and/or <i>JAK</i> driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia
Qi Zhang, Ce Shi, Lina Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2015
Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models
Juliana Benito, Marc S Ramirez, Niki Zacharias Millward, et al.
Journal for Immunotherapy of Cancer
|
September 10, 2025
Innate and adaptive immune features associated with immune-related adverse events
Shaheen Khan, Venkat S Malladi, Mitchell S von Itzstein, et al.
Page
of 21
Search research articles
Search
Showing results (191-200 of 206) with videos related to
Sort By:
Page
of 21
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
February 22, 2018
Disruption of Wnt/β-Catenin Exerts Antileukemia Activity and Synergizes with FLT3 Inhibition in <i>FLT3</i>-Mutant Acute Myeloid Leukemia
Xuejie Jiang, Po Yee Mak, Hong Mu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
December 9, 2024
Phase I/II Trial of Exportin 1 Inhibitor Selinexor plus Docetaxel in Previously Treated, Advanced KRAS-Mutant Non-Small Cell Lung Cancer
Mitchell S von Itzstein, Timothy F Burns, Jonathan E Dowell, et al.
Leukemia
|
May 26, 2019
Imipridone ONC212 activates orphan G protein-coupled receptor GPR132 and integrated stress response in acute myeloid leukemia
Takenobu Nii, Varun V Prabhu, Vivian Ruvolo, et al.
Journal for Immunotherapy of Cancer
|
October 28, 2025
Genetic haplotypes in <i>VWA8, OSBPL6,</i> and <i>ADAMTS9-AS2</i> are associated with immune-related adverse effects in ICI-treated patients with cancer
Prithvi Raj, Jialiang Liu, Chengsong Zhu, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 19, 2017
Antileukemia Efficacy and Mechanisms of Action of SL-101, a Novel Anti-CD123 Antibody Conjugate, in Acute Myeloid Leukemia
Lina Han, Jeffrey L Jorgensen, Chris Brooks, et al.
JTO Clinical and Research Reports
|
December 2, 2024
Racial Differences in Systemic Immune Parameters in Individuals With Lung Cancer
Mitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.
Biorxiv : the Preprint Server for Biology
|
June 25, 2024
Differences in systemic immune parameters in individuals with lung cancer according to race
Mitchell S von Itzstein, Jialiang Liu, Hong Mu-Mosley, et al.
Oncotarget
|
March 1, 2018
Inhibition of mTORC1/C2 signaling improves anti-leukemia efficacy of JAK/STAT blockade in <i>CRLF2</i> rearranged and/or <i>JAK</i> driven Philadelphia chromosome-like acute B-cell lymphoblastic leukemia
Qi Zhang, Ce Shi, Lina Han, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 26, 2015
Hypoxia-Activated Prodrug TH-302 Targets Hypoxic Bone Marrow Niches in Preclinical Leukemia Models
Juliana Benito, Marc S Ramirez, Niki Zacharias Millward, et al.
Journal for Immunotherapy of Cancer
|
September 10, 2025
Innate and adaptive immune features associated with immune-related adverse events
Shaheen Khan, Venkat S Malladi, Mitchell S von Itzstein, et al.
Page
of 21